Few trade ideas for the last day of January

( click to enlarge )

KeyCorp (NYSE:KEY) is on the verge of a breakout. The stock has been holding at support $9.07 but facing resistance at $9.50. I wouldn't be surprised if this stock finally gives investors what they have been waiting for. KEY will move very quickly, so keep a very close eye on the stock.

( click to enlarge )

What a rally for Zalicus Inc (NASDAQ:ZLCS) late in the day. We have to believe that this rally will resume in earnest tomorrow. I feel a rally to $.83 and better is in the cards short term. The Accumul/Distrib line is moving up, it means the stock is being accumulated.
( click to enlarge )
Hemispherx BioPharma, Inc (NYSEAMEX:HEB) looks right on the verge of a breakout. The MACD is moving up showing positive momentum while KD line also show buy signal as %K line is on top of %D line. Keep an eye for a possible breakout over $.31
( click to enlarge )
Elan Corporation, plc (ADR) (NYSE:ELN) Nice breakout with decent volume. Momentum picking up with MACD climbing and RSI rising. Look for a quick run to $10.66 then on to $11. Stop loss 9.74
During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog  twitter and newsletter, so you can receive my trade ideas and stock news in real time.  

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.